Anne‐Sophie de Lajarte‐Thirouard

Predictive Value of ¹⁸F-FDG PET and Somatostatin Receptor Scintigraphy in Patients with Metastatic Endocrine Tumors

Étienne Garin, Florence Le Jeune, Anne Devillers et al. · Journal of Nuclear Medicine · 2009 · 232 citations · Full text

Medicine, Nuclear Medicine, Oncology +17

Novel mutation in ferroportin 1 gene is associated with autosomal dominant iron overload

Anne‐Marie Jouanolle, Véronique Douabin-Gicquel, Chantal Halimi et al. · Journal of Hepatology · 2003 · 80 citations

Medicine, Genetics, Molecular Genetics +15

Resection of Hepatocellular Carcinoma in Noncirrhotic Liver: Analysis of Risk Factors for Survival

Eric Dupont-Bierre, Philippe Compagnon, Jean‐Luc Raoul et al. · Journal of the American College of Surgeons · 2005 · 77 citations

Medicine, Oncology, Surgery +14

Squamous Cell Carcinoma Arising in a Hepatic Forgut Cyst

Anne‐Sophie de Lajarte‐Thirouard, Nathalie Rioux‐Leclercq, Karim Boudjéma et al. · Pathology - Research and Practice · 2002 · 61 citations

Medicine, Oncology, Pathology +14

Type 1 and 2 gastric carcinoid tumors: long-term follow-up of the efficacy of treatment with a slow-release somatostatin analogue

Sylvain Manfrédi, Maël Pagenault, Anne‐Sophie de Lajarte‐Thirouard et al. · European Journal of Gastroenterology & Hepatology · 2007 · 43 citations

Medicine, Oncology, Surgery +13